Introduction of Hepcinat-LP Tablets (Ledipasvir and Sofosbuvir)
Hepcinat-LP Tablets combine two potent antiviral agents, Ledipasvir and Sofosbuvir, specifically formulated for treating chronic Hepatitis C virus (HCV) infections. This combination works synergistically to combat the virus and facilitate recovery.
Salt Composition of Hepcinat-LP Tablets
Hepcinat-LP Tablets contain:
- Ledipasvir (90mg)
- Sofosbuvir (400mg)
Uses of Hepcinat-LP Tablets
- Primarily used in the treatment of chronic Hepatitis C virus (HCV) infection.
Benefits of Hepcinat-LP Tablets
Hepcinat-LP Tablets effectively reduce the viral load of Hepatitis C in the body, helping to resolve the infection and improve liver health. The combination of Ledipasvir and Sofosbuvir enhances treatment efficacy and shortens the duration of therapy.
Side Effects of Hepcinat-LP Tablets
Common side effects may include:
- Fatigue
- Headache
- Nausea
- Insomnia (difficulty sleeping)
- Anemia (low red blood cell count)
Consult your healthcare provider if any side effects persist or worsen.
Risks to Consider
- Pregnancy and Breastfeeding: Consult your doctor before use.
- Alcohol: Avoid consumption during treatment to prevent liver strain.
- Kidney and Liver Health: Use with caution in patients with existing liver or kidney conditions. Inform your healthcare provider of any history of liver disease.
Dosage of Hepcinat-LP Tablets
Take Hepcinat-LP Tablets as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water, with or without food. Complete the full course of treatment, even if you start to feel better.
